Neurotoxic Health Hazards of Long-Term Low-Level Exposure to Organophosphate (OP) Compounds in in Hula Valley
NCT00671866 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2008-05-05
Summary
During 1987-1991, WHO supported studies of exposures and short term neurobehavioral effects in a cohort (n=200) with occupational and community exposures to pesticide drift containing organophosphates from orchards and cotton fields in the Hula Valley. We aim (1) to re-examine neurobehavioral outcomes in members of the original cohort and (2) to examine cognitive effects in children with residential exposures. In adults, we will carry out assays of alkyl phosphates, PON1 (paraoxonase-1), NTE (Neuropathy Target Esterase), neurobehavioral tests of cognitive and performance skills, nerve conduction measurements and mood status. We will carry out Psycho-Didactic tests in children. The findings will advance knowledge on delayed term health effects of lengthy everyday exposure to OP pesticides and guide regulatory policy.
Conditions
Sponsors & Collaborators
-
Shaare Zedek Medical Center
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
Countries
- Israel
Study Locations
More Related Trials
-
Haloperidol for Delirium in Adult Critically Ill Patients
NCT03628391 ·Status: TERMINATED ·Phase: PHASE3
-
Pattern of Acute Antipsychotic Drug- Toxicity in Children
NCT06125275 ·Status: NOT_YET_RECRUITING
-
The Acute Effect of Hypericum Perforatum on Short-Term Memory in Healthy Adults
NCT02862236 ·Status: COMPLETED ·Phase: PHASE4
-
Haloperidol Prophylaxis in Older Emergency Department Patients
NCT01530308 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital
NCT02103881 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Uridine on GABA and High Energy Phosphate Levels in Healthy Volunteers
NCT01261260 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control
NCT00660751 ·Status: COMPLETED ·Phase: NA
-
Effects of Acute Prucalopride Administration in Healthy Volunteers
NCT03863366 ·Status: COMPLETED ·Phase: NA
-
Treatment Strategies in CHS
NCT04176055 ·Status: COMPLETED ·Phase: PHASE4
-
Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction
NCT03065998 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Brain Activity Under the Influence of JWH
NCT06044415 ·Status: UNKNOWN ·Phase: NA
-
Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
NCT06395428 ·Status: RECRUITING ·Phase: PHASE4
-
Benzo[a]Pyrene Ultralow Dose-Response Study
NCT03318978 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users
NCT00902772 ·Status: COMPLETED ·Phase: PHASE1
-
Psychopharmacological Treatment of Emotional Distress
NCT06133114 ·Status: RECRUITING ·Phase: PHASE4
-
Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
NCT02824627 ·Status: COMPLETED ·Phase: PHASE2
-
Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self
NCT03736980 ·Status: COMPLETED ·Phase: NA
-
A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865
NCT02138500 ·Status: COMPLETED ·Phase: PHASE1
-
Propranolol Versus Propranolol and Clonidine in Sympathetic Hyperactivity After Moderate Traumatic Brain Injury
NCT04833218 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Kinetics of Endocannabinoids in Patients With Chemotherapy Induced Peripheral Neuropathy by Using Medical Cannabis.
NCT04376437 ·Status: UNKNOWN ·Phase: NA
-
THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis
NCT04199468 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome
NCT03090620 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With Post Traumatic Stress Disorder (PTSD)
NCT01325168 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury
NCT03095066 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Salvinorin A in Healthy Controls
NCT00700596 ·Status: COMPLETED ·Phase: EARLY_PHASE1